Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...
Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...
Johnson & Johnson (J&J) MedTech’s Shockwave Medical has commenced the multicentre, prospective FORWARD CAD investigational device exemption (IDE) study of the Javelin coronary intravascular ...
Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced that its intravascular lithotripsy catheter for treatment of calcified peripheral ...
Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries Shockwave C2+ is commercially available for the treatment of de novo coronary artery disease in Europe and select other ...
Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in the U.S. that aims to clear a path through extremely narrowed or blocked blood vessels in ...
Johnson & Johnson has officially launched its Shockwave C2 Aero Coronary IVL Catheter globally. Enhanced deliverability and repositioning capabilities target calcified coronary artery disease The ...